key: cord-0763202-29hqb502
authors: Moghadam, Parna; Blum, Laurent; Ahouach, Btissem; Radjou, Aguila; Lambert, Céleste; Scanvic, Agnès; Martres, Pascale; Decalf, Véronique; Bégon, Edouard; Bachmeyer, Claude
title: Multisystem inflammatory syndrome with particular cutaneous lesions related to COVID 19 in a young adult
date: 2020-07-23
journal: Am J Med
DOI: 10.1016/j.amjmed.2020.06.025
sha: f1cc6a37ce1b2aa9ba9a614e14accdab5602dfa6
doc_id: 763202
cord_uid: 29hqb502

nan

A previously healthy 21-year-old Caucasian man was admitted for vasoplegic shock. He denied any drug intake, did not smoke tobacco or use illicit drugs. He presented fever (39°C) with chest tightness, non-bloody watery diarrhea lasting for 7 days and a rash that had developed for 3 days. On clinical examination, he was febrile (40°C), blood pressure was 80/40 mm Hg, respiratory rate 38/mn, and oxygen saturation 97% in ambient air. An asymptomatic rash was present over the trunk and palms, consisting of erythematous roundshapped macules with a darker and raised rim, 1-3 cm in diameter, along with bilateral conjunctivitis (Figure 1 ). The white cell count was 16,000/mm 3 Cutaneous lesions associated with COVID-19 are present in up to 20% of patients including maculopapular rash, urticarial lesions, petechiae, and chilblains-like lesions. 4 The annular rash in our patient was particular and diagnosis of erythema multiforma and subacute lupus erythematosus were easily ruled out.

Hyperinflammatory shock in children during COVID-19 pandemic

Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic

Multisystem inflammatory syndrome in children and adolescents with COVID-19. Scientific brief

Cutaneous manifestations in COVID-19: Lessons learned from current evidence